Product Information

Registration Status: Active

TRILIPIX MODIFIED RELEASE CAPSULE 135MG is approved to be sold in Singapore with effective from 2013-03-07. It is marketed by ABBOTT LABORATORIES (SINGAPORE ) PTE LTD, with the registration number of SIN14376P.

This product contains Choline Fenofibrate 135mg in the form of CAPSULE, DELAYED-RELEASE PELLETS. It is approved for ORAL use.

This product is manufactured by Fournier Laboratories Ireland Limited in FRANCE, andMylan Laboratories SAS in IRELAND.

It is a Prescription Only Medicine that can only be obtained from a doctor or a dentist, or a pharmacist with a prescription from a Singapore-registered doctor or dentist.

Choline Fenofibrate

Source of information: Drugbank (External Link). Last updated on: 3rd July 18. *Trade Name used in the content below may not be the same as the HSA-registered product.


  1. Health Science Authority of Singapore - Reclassified POM
  2. Drugbank